Provectus Biopharmaceuticals (PVCT) null Earnings

26FebConfirmed
Aug 19
Nov 19
Q3 2019
Feb 20
-0.01
-0.01
-0.01
-0

Details

Expected EPS
N/A
Actual EPS
-0.0047
Surprise EPS
-0
Surprise Percent
+∞%

Description

Provectus Biopharmaceuticals (PVCT) has reported earnings of -0.0047 per share for .

0 Comments

Share your thoughts